National Institutes of Health logo
NIH SBIR

NIH SBIR Fast-Track (Omnibus)

Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.

OpenNational Institutes of HealthUnited States

The NIH SBIR Fast-Track Omnibus is a combined Phase I and Phase II application mechanism that allows U.S. small businesses to submit both phases in a single application reviewed by a single study section. Issued jointly under R43 (Phase I component) and R44 (Phase II component) activity codes, Fast-Track awards cover the full Phase I feasibility period (typically six months, capped at $306,872) foโ€ฆ

Same NIH-mission scope as Phase I and II. Reserved for applicants who already have a fully developed Phase II plan and can defend the entire project trajectory in one application.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.5 Jan 2027
Decision timeiTypical time from the deadline to the funder's decision.36 weeks
Project durationiHow long the funded work is expected to run.6โ€“30 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$130M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
National Institutes of Health logo
Open

Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the design and early validation of frameworks โ€” guidelines, protocols and standard procedures โ€” for building and deploying multimodal medical AI reliably.

AIMedtech
$300KOct'26
National Institutes of Health logo
Open

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds a clinical centre inside a consortium testing how to use anti-obesity medication in children without harming their growth or mental health.

Biotech
$1MOct'26
National Institutes of Health logo
Open

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the single centre that runs statistics, data and coordination for the consortium testing anti-obesity medication in children.

Oct'26
National Institutes of Health logo
Open

Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.

Biotech
Oct'26
National Institutes of Health logo
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.

BiotechMedtech+1
Oct'26
National Institutes of Health logo
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.

BiotechMedtech
$250KOct'26